Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
---|
08/08/2013 | US20130203774 Novel compounds, use and preparation thereof |
08/08/2013 | US20130203764 Treatment of cancer/inhibition of metastasis |
08/08/2013 | US20130202573 Thioacetate compounds, compositions and methods of use |
08/07/2013 | EP2623498A1 Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
08/07/2013 | EP2623497A1 Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
08/07/2013 | EP2623492A1 Cyclohexane derivative compound |
08/07/2013 | CN103237794A P2X4 receptor antagonist |
08/07/2013 | CN103232402A Method for extracting refined phenazine from RT base wastes |
08/07/2013 | CN103232359A Environmental-friendly nitrile hydrolysis method |
08/07/2013 | CN102056902B Imidazolidine derivatives |
08/06/2013 | US8501947 Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine |
08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
08/06/2013 | US8501035 Absorption medium for removing acid gases from a fluid stream |
08/06/2013 | CA2529949C Antiviral compounds and methods |
08/01/2013 | WO2013110433A1 Azaheterocyclic compounds |
08/01/2013 | WO2013110134A1 Heterocyclic compounds and methods for their use |
08/01/2013 | US20130197226 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex |
08/01/2013 | US20130196952 Heterocyclic derivatives for the treatment of diseases |
07/31/2013 | EP2619184A2 Deubiquitinase inhibitors and methods for use of the same |
07/31/2013 | EP2619178A1 Substituted benzamide compounds |
07/31/2013 | CN103224474A Synthesis of tetracyclines and analogues thereof |
07/31/2013 | CN103224470A Preparation method and application of quinoxaline-6-phenylhydrazone derivants |
07/30/2013 | US8497374 Process for preparing and purifying bortezomib |
07/30/2013 | US8497373 Phosphonic acid compounds as inhibitors of serine proteases |
07/30/2013 | US8497369 Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production |
07/30/2013 | US8497265 Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors |
07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
07/25/2013 | US20130190288 Benzyl sulfonamide derivatives as rorc modulators |
07/24/2013 | EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
07/24/2013 | EP2616447A1 Pyrazine derivatives as enac blockers |
07/24/2013 | EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
07/24/2013 | CN103221396A Buguanide derivative compound |
07/24/2013 | CN103221125A Acid gas absorbent composition |
07/24/2013 | CN103214425A Preparation method of 2-quinoxaline methylene hydrazine cyanoacetic acid-N4-oxide |
07/24/2013 | CN103214424A Synthesis method of pyrazine methylamine derivative |
07/24/2013 | CN103214409A Synthesis of tetracyclines and analogues thereof |
07/24/2013 | CN103214337A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
07/24/2013 | CN101274945B Organometallic complex, and light-emitting element, light-emitting device and electronic device including the organometallic complex |
07/24/2013 | CN101212903B Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
07/23/2013 | US8492546 Co-crystals and pharmaceutical compositions comprising the same |
07/23/2013 | US8492427 Isoindolones derivatives as MEK kinase inhibitors and methods of use |
07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
07/23/2013 | CA2534675C Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
07/18/2013 | US20130184292 Processes for Making Compounds Useful as Inhibitors of ATR Kinase |
07/18/2013 | US20130184277 Adamantyl diamide derivatives and uses of same |
07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
07/18/2013 | US20130184222 Therapeutically active compositions and their methods of use |
07/17/2013 | CN103209967A Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
07/17/2013 | CN103209966A Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
07/17/2013 | CN103209949A Halogenated indenones and method for producing optically active indanones or optically active indanols by using same |
07/17/2013 | CN101528695B Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
07/16/2013 | US8487135 Catalyst and process for preparing an amine |
07/16/2013 | US8486969 Therapeutic compounds |
07/16/2013 | US8486940 Inhibitors |
07/16/2013 | US8486544 Quinoxaline derivatives and organic light-emitting diodes comprising the same |
07/16/2013 | CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
07/16/2013 | CA2543590C Arthropod repellent pharmacophore models, compounds identified as fitting the pharmacophore models, and methods of making and using thereof |
07/11/2013 | US20130178625 P 2 x 4 receptor antagonist |
07/11/2013 | US20130178482 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)ethoxy)phenyl)butyl) carbamimidoyl)pyrazine-2-carboxamide |
07/11/2013 | US20130177507 Quick Destruction of the Streptococcus Mutans that is Responsible for Tooth Decay |
07/10/2013 | EP2611771A1 New compounds, pharmaceutical compositions and uses thereof |
07/10/2013 | CN103201396A Non-metal tanning |
07/10/2013 | CN103201260A Drug derivatives |
07/10/2013 | CN103193702A Functionalization method for nitrogenous heterocyclic compound |
07/10/2013 | CN103193568A Selective hydrogenation reduction method of fluorine-containing aromatic hydrocarbon derivative |
07/09/2013 | US8481734 Pyrazine derivatives and uses thereof, including in medical imaging and visualization applications |
07/09/2013 | US8481725 Cycloalkylcarbonylamino acid derivative and process for producing the same |
07/09/2013 | US8481544 Antibacterial compositions |
07/09/2013 | US8481543 Compounds for treating parasitic disease |
07/09/2013 | US8481534 5- and 6-membered heterocyclic compounds |
07/09/2013 | CA2516407C Heteroarylcarbamoylbenzene derivatives |
07/04/2013 | WO2013098837A2 A bis-quinaldine compound and a process for preparing the same |
07/04/2013 | WO2013051024A3 Quinoline-, quinoxaline or benzothiazole based cysteinyl leukotriene antagonists (ltc4) |
07/04/2013 | US20130172560 Processes for making cyclopropyl amide derivatives and intermediates associated therewith |
07/04/2013 | US20130172367 2-Alkyl-Cycloalk(en)yl-Carboxamides |
07/04/2013 | US20130172315 Substituted anilines as ccr(4) antagonists |
07/04/2013 | DE10148438B4 Elektrochrome Vorrichtung Electrochromic device |
07/03/2013 | EP2610234A1 Catalytic radiofluorination |
07/03/2013 | EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes |
07/03/2013 | EP2609072A1 Chalcone structure fluorescence dye for embryonic stem cell probe |
07/03/2013 | EP2608666A1 Phenylamidines having a high fungicidal activity and use thereof |
07/03/2013 | CN101970418B Pyrazine derivative and its uses as protein kinase inhibitor |
07/02/2013 | US8476475 Premixture for preparing an absorbent for removing acidic gases from fluid streams |
07/02/2013 | US8476436 Method for enhancing luminescence intensity of clytin-II |
07/02/2013 | US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
07/02/2013 | US8476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
07/02/2013 | US8476269 Pyridine and pyrazine derivative for the treatment of CF |
07/02/2013 | US8476038 Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid |
06/27/2013 | WO2013096771A1 Non-systemic tgr5 agonists |
06/27/2013 | WO2013096744A1 Hepatitis b antiviral agents |
06/27/2013 | WO2013094951A1 Compound for organic optoelectronic device, organic light-emitting diode containing same, and display device comprising organic light-emitting diode |
06/27/2013 | WO2013092941A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
06/27/2013 | US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists |
06/27/2013 | CA2857344A1 Hepatitis b antiviral agents |
06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
06/26/2013 | CN103172523A Method for realizing selective N-methylation of primary amine |
06/26/2013 | CN103172512A Cajanin compound with similar structures, as well as preparation method and application thereof |
06/26/2013 | CN102766534B Method for separating alkaline scent ingredients from main stream smoke of cigarettes and application |
06/26/2013 | CN101910138B Herbicidal compounds |